Panic disorder: When symptoms have no apparent physical cause

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Patients with undiagnosed panic disorder often have symptoms of several associated physical and social problems, and they frequently seek help initially from their primary care physician. Therefore, it is important to be knowledgeable in diagnosis and treatment of panic disorder and to consider it in differential diagnosis in patients reporting non-psychiatric complaints. Although the underlying pathophysiology of panic disorder is still unclear, current research suggests that an imbalance of several neurotransmitter systems may be responsible. Many effective cognitive, behavioral, and pharmacologic methods are available, and patients may require a combination of approaches. Selective serotonin reuptake inhibitors are emerging as first- line therapy because of their demonstrated efficacy and tolerability. Tricyclic antidepressants and monoamine oxidase inhibitors also have been used successfully, and high-potency benzodiazepines are an option when rapid onset of drug activity is desired. Effective treatment of panic disorder can significantly decrease hospitalizations, reduce unnecessary healthcare expenditures, and improve patient quality of life.

Original languageEnglish (US)
JournalPostgraduate Medicine
Volume101
Issue number1
StatePublished - Jan 1997
Externally publishedYes

Fingerprint

Panic Disorder
Monoamine Oxidase Inhibitors
Tricyclic Antidepressive Agents
Social Problems
Serotonin Uptake Inhibitors
Primary Care Physicians
Health Expenditures
Benzodiazepines
Neurotransmitter Agents
Hospitalization
Differential Diagnosis
Therapeutics
Quality of Life
Delivery of Health Care
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Panic disorder : When symptoms have no apparent physical cause. / Katerndahl, David A.

In: Postgraduate Medicine, Vol. 101, No. 1, 01.1997.

Research output: Contribution to journalArticle

@article{06d008731934417fa659da3a3ff999eb,
title = "Panic disorder: When symptoms have no apparent physical cause",
abstract = "Patients with undiagnosed panic disorder often have symptoms of several associated physical and social problems, and they frequently seek help initially from their primary care physician. Therefore, it is important to be knowledgeable in diagnosis and treatment of panic disorder and to consider it in differential diagnosis in patients reporting non-psychiatric complaints. Although the underlying pathophysiology of panic disorder is still unclear, current research suggests that an imbalance of several neurotransmitter systems may be responsible. Many effective cognitive, behavioral, and pharmacologic methods are available, and patients may require a combination of approaches. Selective serotonin reuptake inhibitors are emerging as first- line therapy because of their demonstrated efficacy and tolerability. Tricyclic antidepressants and monoamine oxidase inhibitors also have been used successfully, and high-potency benzodiazepines are an option when rapid onset of drug activity is desired. Effective treatment of panic disorder can significantly decrease hospitalizations, reduce unnecessary healthcare expenditures, and improve patient quality of life.",
author = "Katerndahl, {David A}",
year = "1997",
month = "1",
language = "English (US)",
volume = "101",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "1",

}

TY - JOUR

T1 - Panic disorder

T2 - When symptoms have no apparent physical cause

AU - Katerndahl, David A

PY - 1997/1

Y1 - 1997/1

N2 - Patients with undiagnosed panic disorder often have symptoms of several associated physical and social problems, and they frequently seek help initially from their primary care physician. Therefore, it is important to be knowledgeable in diagnosis and treatment of panic disorder and to consider it in differential diagnosis in patients reporting non-psychiatric complaints. Although the underlying pathophysiology of panic disorder is still unclear, current research suggests that an imbalance of several neurotransmitter systems may be responsible. Many effective cognitive, behavioral, and pharmacologic methods are available, and patients may require a combination of approaches. Selective serotonin reuptake inhibitors are emerging as first- line therapy because of their demonstrated efficacy and tolerability. Tricyclic antidepressants and monoamine oxidase inhibitors also have been used successfully, and high-potency benzodiazepines are an option when rapid onset of drug activity is desired. Effective treatment of panic disorder can significantly decrease hospitalizations, reduce unnecessary healthcare expenditures, and improve patient quality of life.

AB - Patients with undiagnosed panic disorder often have symptoms of several associated physical and social problems, and they frequently seek help initially from their primary care physician. Therefore, it is important to be knowledgeable in diagnosis and treatment of panic disorder and to consider it in differential diagnosis in patients reporting non-psychiatric complaints. Although the underlying pathophysiology of panic disorder is still unclear, current research suggests that an imbalance of several neurotransmitter systems may be responsible. Many effective cognitive, behavioral, and pharmacologic methods are available, and patients may require a combination of approaches. Selective serotonin reuptake inhibitors are emerging as first- line therapy because of their demonstrated efficacy and tolerability. Tricyclic antidepressants and monoamine oxidase inhibitors also have been used successfully, and high-potency benzodiazepines are an option when rapid onset of drug activity is desired. Effective treatment of panic disorder can significantly decrease hospitalizations, reduce unnecessary healthcare expenditures, and improve patient quality of life.

UR - http://www.scopus.com/inward/record.url?scp=1842296394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842296394&partnerID=8YFLogxK

M3 - Article

C2 - 9008694

AN - SCOPUS:1842296394

VL - 101

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 1

ER -